Tylenol Controversy
Eddie raises concerns about Tylenol after the company missed a critical FDA deadline, suggesting potential safety issues linked to recent deaths. As the conversation unfolds, they speculate on the implications of corporate accountability and the state of the economy affecting product safety. The lighthearted banter shifts to a humorous debate about pain relief options, showcasing their unique dynamic.In this clip
From this podcast
The Joe Rogan Experience
Joe Rogan Experience #24 - Eddie Bravo
Related Questions